Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2021, 3(5); doi: 10.25236/IJFM.2021.030504.

Investigation and Analysis of the Current Status of Patients with Hepatitis C Combined with Tuberculosis Infection in the Hospital


Lin Yang1, Kunwei Li2

Corresponding Author:
Kunwei Li

1College of Health, Yunnan Business Administration School, Kunming 650000, Yunnan, China

2Department of Ultrasound, Anning First People's Hospital, Anning 650304, Yunnan, China


HCV infection causes acute and chronic hepatitis. If it is not treated in time, it may even develop into liver fibrosis, cirrhosis and liver cancer. Therefore, timely antiviral treatment is very important. In addition, besides being infected with hepatitis C, patients are very likely to have other complications such as hepatitis C combined with tuberculosis. For this reason, this article needs to investigate and analyze the current situation of patients with hepatitis C combined with tuberculosis infection in the hospital. This article mainly uses the methods of investigation, experimental analysis and statistical analysis to sort out and analyze the collected materials. The survey results show that 52 % of hepatitis C patients with tuberculosis infection have undergone surgery. This shows that some hospitals still have certain problems with the handling of medical tools. In order to reduce the incidence of hepatitis C combined with tuberculosis infection, prevention work needs to be done in daily life and iatrogenic behavior.


Hepatitis C, Tuberculosis Infection, Current Status Survey, Analysis Research

Cite This Paper

Lin Yang, Kunwei Li. Investigation and Analysis of the Current Status of Patients with Hepatitis C Combined with Tuberculosis Infection in the Hospital. International Journal of Frontiers in Medicine (2021), Vol. 3, Issue 5: 27-32. https://doi.org/10.25236/IJFM.2021.030504.


[1] Dong Ni, Zhao Jing, Luo Hongmei, et al. Investigation and nursing management of hepatitis C in maintenance hemodialysis patients[J]. Clinical Medical Research and Practice, 2017, 08(v.2):154-155.

[2] Wang Qin, Rao Huiying, Yu Ning, et al. Analysis of adult chronic hepatitis C complicated diseases and medication status[J]. Chinese Journal of Hepatology, 2018, 026(003):225-232.

[3] Chen Yongzhi. Clinical analysis of patients with hepatitis C[J]. Everyone's Health Journal, 2017, 11(001):55-56.

[4] Xu Jinfeng, Qiu Lixia, Yu Haibin, et al. Predictive value of hypoxanthine triphosphate gene polymorphism on ribavirin combined with direct antiviral drugs in the treatment of hemolytic anemia caused by hepatitis C[J]. Clinical liver and gallbladder Journal of Diseases, 2021, 37(10): 2320-2323.

[5] Zhang Yi, Wang Xiaochun, Zhang Man, et al. 2016 Urumqi City Hepatitis C diagnosis and report data quality verification analysis [J]. International Journal of Virology, 2018, 025(001): 19-24.

[6] Wang Jia. About 60 cases of hepatitis C infection and clinical examination[J]. Medical Aesthetics and Cosmetology, 2018, 027(018): 79-80.

[7] Wang Yunxia, Maiwulani, Li Xiang, et al. Analysis of diagnosis and report quality of hepatitis C cases in medical institutions in Urumqi [J]. Health Vision, 2019, 000(007): 5-6.

[8] Guo Yan, Ning Tielin, Zhou Ning. HCV infection status and influencing factors among drug users in Tianjin from 2011 to 2015[J]. International Journal of Virology, 2017, 024(003):178-183.

[9] Qin Ting. Clinical analysis of multiple biochemical indicators for dynamic monitoring of patients with chronic hepatitis C infection[J]. Diet Health Care, 2018, 5(043): 1-2.

[10] Chang Feng, Duan Cheng Axin, Jin Xunze, et al. Analysis of the current status of hepatitis C treatment in my country and related medical security compensation mechanisms and suggestions[J]. Chinese Pharmacy, 2018, 029(002):151-155.

[11] Wei Lai. Research progress of Danorevir and its combined PR regimen in the treatment of chronic hepatitis C[J]. Chinese Journal of Clinical Infectious Diseases, 2018, 011(002): 84-89.

[12] Zhang Dan, Wang Fang, Song Kaifa. Analysis of the epidemiological characteristics of hepatitis C in Jingzhou from 2006 to 2017[J]. Forum on Preventive Medicine, 2019, Volume 25, Issue 1, pp. 51-53, 2019.